Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog

Xenobiotica

Volumn 27, Issue 10, 1997, Pages 1053-1070

  Naitoh, T ^a   Mishima, M ^a   Kawaguchi, S ^a   Matsui, K ^a   Andoh, T ^a   Kagei, K ^a   Kakiki, M ^a   Yuzuriha, T ^a   Horie, T ^a  

^a EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 (3 CYANO 1 HYDROXYPROPYL) 6 BENZOTHIAZOLYL] 5 METHOXYMETHYL 2 OXAZOLIDINONE; CARBON 14; MONOAMINE OXIDASE A INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; FECES; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT; SPECIES DIFFERENCE; URINARY EXCRETION;

ABSORPTION; ANIMALS; BENZOTHIAZOLES; BILIARY TRACT; BLOOD PROTEINS; CARBON RADIOISOTOPES; DOGS; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; OXAZOLES; OXAZOLIDINONES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES; TISSUE DISTRIBUTION;

EID: 0030826623     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982597240028     Document Type: Article

References (10)

1. BLACKWELL, B., 1981, Adverse effects of antidepressant drugs. Part 1: Monoamine oxidase inhibitors and tricyclics. Drugs, 21, 201-219.
2. GOLDMAN, L. S., ALEXANDER, R. C. and LUCHINS, D. J., 1986, Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects. Journal of Clinical Psychiatry, 47, 225-229.
3. KAGAYA, T., KAJIWARA, A., NAGATO, S., AKASAKA, K. and KUBOTA, A., 1996, E2011, a novel, selective and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics, 278, 243-251.
4. NAITOH, T., HORIE, T., NAGATO, S., KAGAYA, T., KUBOTA, A. and AKASAKA, K., 1994, Application of pharmacokinetic studies to a novel antidepressant, E2011. Xenobiotica, 24, 819-826.
5. NAITOH, T., KAKIKI, M., KOZAKI, T., MISHIMA, M., YUZURIHA, T. and HORIE, T., 1997, Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in the rat. Xenobiotica (in press).
6. RABKIN, J., QUITKIN, F., HARRISON, W., TRICAMO, E. and McGRATH, P., 1984, Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. Journal of Clinical Psychopharmacology, 4, 270-278.
7. RABKIN, J., QUITKIN, F., McGRATH, P., HARRISON, W. and TRICAMO, E., 1985, Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management. Journal of Clinical Psychopharmacology, 5, 2-9.
8. SHERLOCK, S., 1964, Jaundice due to drugs. Proceedings of the Royal Society of Medicine, 57, 881-886.
9. TYRER, P., 1976, Towards rational therapy with monoamine oxidase inhibitors. British Journal of Psychiatry, 128, 354-360.
10. YAMAOKA, K., NAKAGAWA, T. and UNO, T., 1978, Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547-558.